CNY 0.21
(-12.5%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 428.47 Million CNY | -5.73% |
2022 | 192.11 Million CNY | -5.15% |
2021 | 202.55 Million CNY | -2.41% |
2020 | 207.55 Million CNY | -39.0% |
2019 | 340.23 Million CNY | 374.13% |
2018 | 71.75 Million CNY | 362.07% |
2017 | -27.38 Million CNY | -131.99% |
2016 | 85.6 Million CNY | 4.83% |
2015 | 81.65 Million CNY | 39.27% |
2014 | 58.63 Million CNY | 82.74% |
2013 | 32.08 Million CNY | -11.14% |
2012 | 36.1 Million CNY | 23.79% |
2011 | 29.16 Million CNY | 14.7% |
2010 | 25.43 Million CNY | 33.72% |
2009 | 19.01 Million CNY | 26.6% |
2008 | 15.02 Million CNY | 60.0% |
2007 | 9.38 Million CNY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 84.9 Million CNY | 134.67% |
2024 Q1 | 36.18 Million CNY | -40.65% |
2024 Q3 | 76.3 Million CNY | 55.6% |
2023 Q3 | 47.61 Million CNY | 18.34% |
2023 Q1 | 32.29 Million CNY | -25.64% |
2023 Q2 | 40.23 Million CNY | 24.58% |
2023 Q4 | 60.96 Million CNY | 28.03% |
2023 FY | 181.11 Million CNY | -5.73% |
2022 FY | 192.11 Million CNY | -5.15% |
2022 Q1 | 41.35 Million CNY | -20.45% |
2022 Q2 | 48.12 Million CNY | 16.35% |
2022 Q3 | 59.2 Million CNY | 23.03% |
2022 Q4 | 43.43 Million CNY | -26.63% |
2021 Q3 | 40.89 Million CNY | -28.62% |
2021 Q2 | 57.29 Million CNY | 9.4% |
2021 Q1 | 52.37 Million CNY | 41.67% |
2021 FY | 202.55 Million CNY | -2.41% |
2021 Q4 | 51.98 Million CNY | 27.11% |
2020 Q2 | 55.08 Million CNY | 7.13% |
2020 Q4 | 36.96 Million CNY | -42.32% |
2020 FY | 207.55 Million CNY | -39.0% |
2020 Q3 | 64.09 Million CNY | 16.36% |
2020 Q1 | 51.41 Million CNY | -74.6% |
2019 Q1 | 15.78 Million CNY | -68.84% |
2019 FY | 340.23 Million CNY | 374.13% |
2019 Q4 | 202.4 Million CNY | 343.9% |
2019 Q3 | 45.59 Million CNY | -40.35% |
2019 Q2 | 76.44 Million CNY | 384.3% |
2018 Q1 | -9.55 Million CNY | 90.25% |
2018 FY | 71.75 Million CNY | 362.07% |
2018 Q4 | 50.65 Million CNY | 1111.69% |
2018 Q3 | -5 Million CNY | -114.04% |
2018 Q2 | 35.66 Million CNY | 473.31% |
2017 FY | -27.38 Million CNY | -131.99% |
2017 Q1 | 18.58 Million CNY | -55.55% |
2017 Q3 | 117.52 Million CNY | 362.46% |
2017 Q4 | -97.99 Million CNY | -183.38% |
2017 Q2 | 25.41 Million CNY | 36.75% |
2016 FY | 85.6 Million CNY | 4.83% |
2016 Q3 | 15.23 Million CNY | 9.43% |
2016 Q2 | 13.92 Million CNY | -4.8% |
2016 Q1 | 14.62 Million CNY | -58.93% |
2016 Q4 | 41.8 Million CNY | 174.35% |
2015 Q1 | 15.96 Million CNY | -50.85% |
2015 Q2 | 14.67 Million CNY | -8.08% |
2015 Q3 | 13.56 Million CNY | -7.54% |
2015 FY | 81.65 Million CNY | 39.27% |
2015 Q4 | 35.61 Million CNY | 162.52% |
2014 Q4 | 32.48 Million CNY | 222.48% |
2014 FY | 58.63 Million CNY | 82.74% |
2014 Q3 | 10.07 Million CNY | 39.43% |
2014 Q2 | 7.22 Million CNY | -18.43% |
2014 Q1 | 8.85 Million CNY | -19.12% |
2013 Q1 | 5.99 Million CNY | -50.34% |
2013 FY | 32.08 Million CNY | -11.14% |
2013 Q2 | 7.12 Million CNY | 18.92% |
2013 Q3 | 8.01 Million CNY | 12.4% |
2013 Q4 | 10.94 Million CNY | 36.66% |
2012 Q4 | 12.07 Million CNY | 18.06% |
2012 Q1 | 5.55 Million CNY | -42.38% |
2012 FY | 36.1 Million CNY | 23.79% |
2012 Q3 | 10.22 Million CNY | 23.78% |
2012 Q2 | 8.25 Million CNY | 48.72% |
2011 Q1 | 4.9 Million CNY | -31.7% |
2011 Q2 | 6.56 Million CNY | 33.94% |
2011 Q3 | 8.06 Million CNY | 22.76% |
2011 Q4 | 9.63 Million CNY | 19.55% |
2011 FY | 29.16 Million CNY | 14.7% |
2010 Q4 | 7.17 Million CNY | 18.81% |
2010 Q2 | 7.99 Million CNY | 89.73% |
2010 Q3 | 6.04 Million CNY | -24.44% |
2010 FY | 25.43 Million CNY | 33.72% |
2010 Q1 | 4.21 Million CNY | -29.65% |
2009 Q4 | 5.99 Million CNY | 36.37% |
2009 Q3 | 4.39 Million CNY | 0.0% |
2009 FY | 19.01 Million CNY | 26.6% |
2008 FY | 15.02 Million CNY | 60.0% |
2007 FY | 9.38 Million CNY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Cachet Pharmaceutical Co., Ltd. | 1.36 Billion CNY | 68.566% |
Yixintang Pharmaceutical Group Co., Ltd. | 4.78 Billion CNY | 91.045% |
ZJAMP Group Co., Ltd. | 1.31 Billion CNY | 67.446% |
Luyan Pharma Co.,Ltd. | 1.03 Billion CNY | 58.719% |